US Broker Ratings

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a 19.56% Potential Upside for Investors

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, presents an intriguing opportunity for..

Natera, Inc. (NTRA) Stock Analysis: Navigating High Growth and Investor Sentiment in the Healthcare Sector

Investors eyeing the healthcare sector may want to pay close attention to Natera, Inc. (NASDAQ: NTRA), a prominent player in the diagnostics and research industry. With..

UnitedHealth Group (UNH) Stock Analysis: An Investor’s Perspective on Its 27.92% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, commands a formidable market capitalization of $338.03 billion. As a leader in the healthcare plans..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Attractive 24.65% Upside Potential

GE HealthCare Technologies Inc. (GEHC) is establishing itself as a key player within the healthcare sector, specifically in the medical devices industry. With a market capitalization..

AbbVie Inc. (ABBV) Stock Analysis: Exploring Growth Potential with a 5.38% Upside

AbbVie Inc. (NYSE: ABBV), a prominent player in the healthcare sector, particularly within the drug manufacturing industry, continues to capture the attention of investors with its..

Agilent Technologies, Inc. (A) Stock Analysis: Navigating a 1.53% Potential Upside with Strong Analyst Confidence

Agilent Technologies, Inc. (NYSE: A), a leader in the healthcare sector, particularly in the diagnostics and research industry, is capturing investor attention with its robust market..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Growth Potential with a 4.01% Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to capture investor interest with its robust pipeline of biopharmaceutical products and an attractive..

The Cigna Group (CI) Stock Analysis: Potential Upside of 25.67% Amid Strong Buy Ratings

The Cigna Group (NYSE: CI), a venerable name in the healthcare sector, is capturing investor attention with its robust market position and impressive potential upside. Valued..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Robust Growth Potential Amidst Biotech Innovations

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the healthcare sector, specifically within biotechnology. With a market capitalization of $133.28 billion, Vertex’s robust..

Danaher Corporation (DHR) Stock Analysis: Exploring Growth Potential and Analyst Confidence

As a titan in the healthcare sector, Danaher Corporation (NYSE: DHR) continues to capture the attention of investors with its extensive reach in the diagnostics and..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Biotech Powerhouse with 19.94% Potential Upside

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, continues to hold the investment community’s attention. Headquartered in Basel, Switzerland, BeOne specializes in oncology,..

Veeva Systems Inc. (VEEV) Stock Analysis: Strong Growth in Healthcare Tech Amidst a 5.92% Potential Upside

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based solutions for the life sciences industry, presents an intriguing opportunity for investors within the healthcare sector. With..

Humana Inc. (HUM) Stock Analysis: Balancing Growth Potential with Market Volatility

Investors eyeing opportunities within the healthcare sector should look closely at Humana Inc. (NYSE: HUM), a major player in the healthcare plans industry. With a substantial..

Sanofi (SNY) Stock Analysis: Capitalizing on a 30.68% Potential Upside

Sanofi (NASDAQ: SNY), a heavyweight in the healthcare sector, has long been a pivotal player in the global pharmaceutical landscape. Based in Paris, France, Sanofi is..

Zoetis Inc. (ZTS) Stock Analysis: Evaluating a 35% Upside Potential for Investors

Zoetis Inc. (NYSE: ZTS), a prominent player in the healthcare sector focusing on the animal health industry, is attracting investor attention with its significant upside potential..

Pfizer, Inc. (PFE) Stock Analysis: A Look at Dividend Yield Amidst Market Dynamics

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, has long been a cornerstone for investors seeking exposure to the drug manufacturing industry. With its..

Gilead Sciences, Inc. (GILD): Investor Outlook Amid Robust Revenue Growth and Strategic Collaborations

Gilead Sciences, Inc. (NASDAQ: GILD) stands as a giant within the healthcare sector, particularly in the drug manufacturing industry. Headquartered in Foster City, California, this biopharmaceutical..

Novartis AG (NVS) Investor Outlook: Analyzing Growth Potential Amidst a Strong 3.26% Dividend Yield

For investors looking to diversify their portfolios with a robust player in the healthcare sector, Novartis AG (NYSE: NVS) presents an intriguing opportunity. With a market..

Merck & Company, Inc. (MRK) Stock Analysis: Exploring a 3.28% Potential Upside Amid Strong Buy Ratings

Merck & Company, Inc. (NYSE: MRK) stands as a formidable player in the healthcare sector, boasting a substantial market capitalization of $367.07 billion. As a significant..

Johnson & Johnson (JNJ)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds